Evidence map›Paper›PMID 30352603›Full record

ArticleParticle and fibre toxicology2018

Usefulness of myeloperoxidase as a biomarker for the ranking of pulmonary toxicity of nanomaterials.

Taisuke Tomonaga, Hiroto Izumi, Yukiko Yoshiura, Toshihiko Myojo, Takako Oyabu, Byeong-Woo Lee, Takami Okada, Takashi Marui, Ke-Yong Wang, Masaru Kubo and 5 more

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nearly free surface silanols are the critical molecular moieties that initiate the toxicity of silica particles.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Taisuke TomonagaInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan. t-tomonaga@med.uoeh-u.ac.jp.ORCID 0000-0003-3583-3785
Hiroto IzumiInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Yukiko YoshiuraInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Toshihiko MyojoInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Takako OyabuInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Byeong-Woo LeeInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Takami OkadaInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Takashi MaruiInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Ke-Yong WangShared-Use Research Center, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Masaru KuboDepartment of Chemical Engineering, Hiroshima University, Higashi-Hiroshima, 739-8528, Japan.
Manabu ShimadaDepartment of Chemical Engineering, Hiroshima University, Higashi-Hiroshima, 739-8528, Japan.
Shingo NoguchiDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Chinatsu NishidaDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Kazuhiro YateraDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
Yasuo MorimotoInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan.
University of Occupational and Environmental Health Japan · JPHiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order to examine whether myeloperoxidase (MPO) can be a useful marker for evaluating the pulmonary toxicity of nanomaterials, we analyzed MPO protein in bronchoalveolar lavage fluid (BALF) samples obtained from previous examinations of a rat model. In those examinations we performed intratracheal instillation exposures (dose: 0.2-1.0 mg) and inhalation exposures (exposure concentration: 0.32-10.4 mg/m

resultsIntratracheal instillation of high toxicity NiO, CeO

conclusionThese data suggest that MPO can be a useful biomarker for the ranking of the pulmonary toxicity of nanomaterials, especially at 1 month after exposure, in both intratracheal instillation and inhalation exposure.

Indexed as

AnimalsBiomarkersBronchoalveolar Lavage FluidChemokinesInhalation ExposureLungMacrophages, AlveolarMaleNanoparticlesNeutrophilsPeroxidaseRats, Inbred F344BiomarkersChemokinesPeroxidaseBiomarkerInhalationIntratracheal instillationMyeloperoxidaseNanomaterialPulmonary toxicityRat

Identifiers

PMID30352603
PMCPMC6199695
OpenAlexW2896960302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.